CH578582A5 - - Google Patents

Info

Publication number
CH578582A5
CH578582A5 CH1613872A CH1613872A CH578582A5 CH 578582 A5 CH578582 A5 CH 578582A5 CH 1613872 A CH1613872 A CH 1613872A CH 1613872 A CH1613872 A CH 1613872A CH 578582 A5 CH578582 A5 CH 578582A5
Authority
CH
Switzerland
Application number
CH1613872A
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH578582A5 publication Critical patent/CH578582A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cephalosporin Compounds (AREA)
CH1613872A 1971-11-19 1972-11-06 CH578582A5 (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20058771A 1971-11-19 1971-11-19
US243438A US3887549A (en) 1971-11-19 1972-04-12 Process for preparing 7-acylamido-7-methoxy-3-cephem-4-carboxylic acid, esters and salts

Publications (1)

Publication Number Publication Date
CH578582A5 true CH578582A5 (enExample) 1976-08-13

Family

ID=26895900

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1613872A CH578582A5 (enExample) 1971-11-19 1972-11-06

Country Status (5)

Country Link
US (1) US3887549A (enExample)
CA (1) CA1009228A (enExample)
CH (1) CH578582A5 (enExample)
DD (1) DD101411A5 (enExample)
NL (1) NL7214679A (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives
US4059578A (en) * 1974-09-09 1977-11-22 Smithkline Corporation 7-Substituted mercaptoacetamido cephamycins
FR2323389A1 (fr) * 1975-09-09 1977-04-08 Squibb & Sons Inc 7-methoxy-7-a-ureido (thienyl et furyl)-acetamidocephalosporines
US4063019A (en) 1976-03-30 1977-12-13 E. R. Squibb & Sons, Inc. [[[(2,4-Dioxo-1-imidazolidinyl)amino]carbonyl]amino]-acetylcephalosporin derivatives
US4165429A (en) * 1976-06-28 1979-08-21 Yamanouchi Pharmaceutical Co., Ltd. 7α-METHOXY-CEPHALOSPORANIC ACID DERIVATIVES
US4308259A (en) * 1979-03-01 1981-12-29 Beecham Group Limited Penicillin derivatives
HU188874B (en) * 1983-04-19 1986-05-28 Biogal Gyogyszergyar,Hu Process for producing new 7-acylamido-3-acylaminomethyl-ceph-3-eme-4-carboxylic acid derivatives and pharmaceutically acceptable salts thereof
FR2722790B1 (fr) * 1994-07-19 1996-10-04 Roussel Uclaf Nouvelles cephalosporines comportant en position 7 un radical benzyloxymino subtitue, leur procede de preparation leur application comme medicaments

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3597421A (en) * 1969-01-21 1971-08-03 Lilly Co Eli Cephalosporin sulfoxides
US3718644A (en) * 1970-06-30 1973-02-27 Merck & Co Inc Antibiotic separation and purification
US3705897A (en) * 1970-07-07 1972-12-12 Lilly Co Eli Method for converting delta**2 cephalosporin to delta**3 cephalosporin
US3719563A (en) * 1970-08-03 1973-03-06 Lilly Co Eli Process for producing 7-(5-amino-5-carboxyvaleramido)-7-methoxycephalosporamic acid

Also Published As

Publication number Publication date
CA1009228A (en) 1977-04-26
NL7214679A (enExample) 1973-05-22
DD101411A5 (enExample) 1973-11-05
US3887549A (en) 1975-06-03

Similar Documents

Publication Publication Date Title
ATA136472A (enExample)
AR196074A1 (enExample)
AU2658571A (enExample)
AU2691671A (enExample)
AU2742671A (enExample)
AU2894671A (enExample)
AU2485671A (enExample)
AU2726271A (enExample)
AU2952271A (enExample)
AU2684071A (enExample)
AU3005371A (enExample)
AU2941471A (enExample)
AU2564071A (enExample)
AU2473671A (enExample)
AU2836771A (enExample)
AU3038671A (enExample)
AU2503871A (enExample)
AU3025871A (enExample)
AU2577671A (enExample)
AU2588771A (enExample)
AU2654071A (enExample)
AU2456871A (enExample)
AU2669471A (enExample)
AU2455871A (enExample)
AU2938071A (enExample)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased